Atlas Trials

A Study to Evaluate the Long-term Safety of HS-10380 in Patients With Schizophrenia

Clinical trial NCT07759869 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07759869
Sponsor
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Status
NOT_YET_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
SCHIZOPHRENIA 1 (Disorder)
Start date
2026-09-09
Primary completion
2028-07-31
Enrollment
500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.